MMLV Reverse Transcriptase Mutants for Thermostable cDNA Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing MMLV and AMV reverse transcriptase enzymes face limitations in thermostability and RNase H activity, leading to inefficiencies in synthesizing long cDNA, particularly with RNA molecules having strong secondary structures.
Innovation Solution
Development of MMLV reverse transcriptase mutants with specific amino acid substitutions, such as I61R, Q68R, Q79R, L99R, and E282D, to enhance thermostability and reduce RNase H activity, improving cDNA synthesis efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Temperature
If AMV RTase is used for reverse transcription, then thermostability is improved, but RNase H activity increases causing reduced cDNA yield
Solution Approach 1:
The patent applies parameter changes by introducing specific amino acid substitutions (D524G, E562Q, D583N) into the AMV RTase sequence to modify enzyme properties. These parameter changes in the protein structure reduce RNase H activity while preserving thermostability, resolving the contradiction between these two properties.
Solution Approach 2:
The patent applies local quality by making targeted mutations at specific positions (524, 562, 583) in the RTase sequence. These localized changes affect only the RNase H functional region while leaving other properties like thermostability intact, allowing differential optimization of enzyme properties at different locations.
2Object-generated harmful factors
If MMLV RTase is used for reverse transcription, then RNase H activity is reduced, but thermostability decreases limiting use with structured RNAs
Solution Approach 1:
The patent merges the beneficial properties of MMLV RTase (low RNase H activity) and AMV RTase (high thermostability) by combining the catalytic domain from MMLV with the C-terminal region from AMV. This hybrid construction integrates the advantageous traits of both parent enzymes into a single functional enzyme.
Solution Approach 2:
The patent creates a composite enzyme structure by fusing domains from two different RTase sources (MMLV and AMV). This composite approach allows the enzyme to exhibit properties of both parent enzymes, achieving low RNase H activity combined with high thermostability.
3Temperature
If elevated temperature is used for reverse transcription, then secondary structures are resolved, but RNA integrity and cDNA fidelity decrease
Solution Approach 1:
The patent changes the temperature parameter from the traditional 37°C to 50-65°C by using the thermostable mutant RTase. This parameter change allows reverse transcription at higher temperatures that resolve secondary structures while the engineered enzyme stability prevents degradation and maintains fidelity.
Solution Approach 2:
The patent uses the RTase enzyme to create accurate DNA copies of RNA templates at elevated temperatures. The enzyme's enhanced stability at high temperatures ensures faithful copying of the RNA sequence despite the harsh conditions, maintaining cDNA fidelity.
4Temperature
If MMLV RTase is used at elevated temperature, then secondary structures are accessed, but enzyme activity and cDNA length decrease
Solution Approach 1:
The patent changes the optimal temperature parameter from 37°C to 50-65°C through amino acid mutations. This parameter shift allows the enzyme to maintain high activity at elevated temperatures, enabling access to secondary structures without sacrificing productivity or cDNA length.
Solution Approach 2:
The patent creates a dynamic enzyme that can function across a broader temperature range. The mutations confer thermal adaptability, allowing the enzyme to maintain optimal activity whether at lower or higher temperatures, providing flexibility for different RNA substrate requirements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The mutants exhibit increased RTase activity and thermostability, enabling more efficient synthesis of full-length cDNA from RNA templates, even at elevated temperatures, overcoming the limitations of wild-type and existing mutant enzymes.
Implementation Method 1
RTase is a critical component of the reverse transcription polymerase chain reaction (RT-PCR) allowing the production of complementary DNA (cDNA) from RNA
Implementation Method 2
RTases, first derived from retroviruses, facilitate the reverse transcription of RNA into cDNA by utilizing RNA-dependent polymerase
Implementation Method 3
RNase H, a non-sequence-specific endonuclease enzyme that catalyzes cleavage of RNA in an RNA/DNA duplex
Implementation Method 4
The mutants exhibit increased RTase activity and thermostability, enabling more efficient synthesis of full-length cDNA from RNA templates, even at elevated temperatures
Data Source
AI summary
The disclosure provides Moloney murine leukemia virus (MMLV) reverse transcriptase (RTase) mutants. The disclosure as provides suitable amino acid positions in MMLV RTase for mutagenesis and methods and kits for using MMLV RTase mutants to synthesize cDNA from RNA templates.